Evidence map›Paper›PMID 36769042›Full record

ArticleInternational journal of molecular sciences2023

Rare Phytocannabinoids Exert Anti-Inflammatory Effects on Human Keratinocytes via the Endocannabinoid System and MAPK Signaling Pathway.

Daniel Tortolani, Camilla Di Meo, Sara Standoli, Francesca Ciaramellano, Salam Kadhim, Eric Hsu, Cinzia Rapino, Mauro Maccarrone

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Beyond Cannabidiol: The Contribution ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. The Potential of Cannabichromene (CBC) as a Therapeutic Agent.The Journal of pharmacology and experimental therapeutics · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel TortolaniDepartment of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.ORCID 0000-0002-6704-9023
Camilla Di MeoDepartment of Bioscience and Technology for Food Agriculture and Environment, University of Teramo, 64100 Teramo, Italy.ORCID 0000-0003-2045-3114
Sara StandoliDepartment of Bioscience and Technology for Food Agriculture and Environment, University of Teramo, 64100 Teramo, Italy.ORCID 0000-0001-5818-3637
Francesca CiaramellanoDepartment of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.ORCID 0000-0002-1899-8628
Salam KadhimInMed Pharmaceuticals Inc., Vancouver, BC V6C 1B4, Canada.
Eric HsuInMed Pharmaceuticals Inc., Vancouver, BC V6C 1B4, Canada.
Cinzia RapinoDepartment of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.ORCID 0000-0002-9759-2449
Mauro MaccarroneEuropean Center for Brain Research (CERC), Santa Lucia Foundation IRCCS, 00143 Rome, Italy.ORCID 0000-0002-3990-2963

Funding

InMed Pharmaceuticals Inc. (Vancouver, Canada) N° PCI0029
6 · The paper itself

Abstract

Increasing evidence supports the therapeutic potential of rare cannabis-derived phytocannabinoids (pCBs) in skin disorders such as atopic dermatitis, psoriasis, pruritus, and acne. However, the molecular mechanisms of the biological action of these pCBs remain poorly investigated. In this study, an experimental model of inflamed human keratinocytes (HaCaT cells) was set up by using lipopolysaccharide (LPS) in order to investigate the anti-inflammatory effects of the rare pCBs cannabigerol (CBG), cannabichromene (CBC), Δ

Indexed as

EndocannabinoidsMitogen-Activated Protein KinasesAnti-Inflammatory AgentsHumansInflammationInterleukin-12KeratinocytesLymphotoxin-alphaSignal TransductionAnti-Inflammatory AgentsEndocannabinoidsInterleukin-12Lymphotoxin-alphaMitogen-Activated Protein Kinasesendocannabinoidsinflammationkeratinocytesphytocannabinoidssignal transduction

Identifiers

PMID36769042
PMCPMC9917187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.